Open AccessReactive perforating collagenosis: a rare side effect associated with sorafenib
Author(s) -
David VegaDíez,
Alba GómezZubiaur,
S. Medina Montalvo
Publication year - 2020
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2020.7138/2020
Subject(s) - medicine , sorafenib , dermatology , presentation (obstetrics) , side effect (computer science) , surgery , pathology , hepatocellular carcinoma , computer science , programming language
We present the case of a patient with a debut of reactive perforating collagenosis associated with the use of Sorafenib for stage IV hepatocarcinoma, very successfully controlled with local corticotherapy and systemic antihistamines. This is an extremely rare side effect associated with this treatment, as only another eleven cases of acquired perforating dermatoses associated with Sorafenib or other multi-kinase inhibitors have been found in the medical literature. Given the unusual nature of this presentation, high clinical suspicion and a correct histopathological study are indispensable for its correct filiation and treatment.